February 17, 2015

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.

February 9, 2015

Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.

February 6, 2015

The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.

February 6, 2015

Rochester Drug Cooperative and Aureus Health Services on Thursday announced a specialty pharmacy services program available to RDC's independent, community pharmacy customers.

February 5, 2015

Food and Drug Commissioner Margaret Hamburg will resign from her post in March.

 

February 3, 2015

Diplomat Pharmacy announced Monday that it has earned the Verified Internet Pharmacy Practice Sites seal of approval from the National Association of Boards of Pharmacy.

February 3, 2015

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

February 2, 2015

Mylan announced that it will acquire certain businesses from specialty women's healthcare company Famy Care Limited for $750 million, with additional contingent payments of up to $50 million. 

January 30, 2015

BioPlus Specialty Pharmacy announced Thursday that URAC, the largest accrediting body for health care, has once again given BioPlus its seal of approval by accrediting it through an on-site process.

January 30, 2015

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).

January 30, 2015

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

January 28, 2015

BioPlus Specialty Pharmacy on Tuesday earned accreditation from two important industry accrediting bodies: Verified Internet Pharmacy Practice Sites and Accreditation Commission for Health Care.

January 28, 2015

Cardinal Health Specialty Solutions on Tuesday announced that it has signed a three-year agreement with RainTree Oncology Services to serve as its exclusive distributor for injectable, infused, oral oncolytic and supportive care specialty medications.

January 28, 2015

"During one of the sessions at the 2008 NACDS Regional Chain Conference, we projected onto the video screen some images of advertisements that NACDS was beginning to use in the Washington, D.C. area. Looking back, one of the things that I remember most was the boldness and strategic focus of the tagline: 'Pharmacies. The face of neighborhood healthcare.' With the 2015 edition of this meeting just days away, it is striking how far we have come!" writes NACDS president and CEO Steve Anderson in his latest blog post. 

January 27, 2015

HIV patients using a mobile app are 2.9 times more likely to be adherent.

January 26, 2015

The Food and Drug Administration last week approved Natpara (parathyroid horomone), which is indicated to control low blood calcium levels in patients who have hypoparathyroidism.

 

January 21, 2015

Drug Channels Institute on Tuesday offered a sneak peek to its 2014-15 Economic Report on Retail, Mail and Specialty Pharmacies with a look at the largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2014.

January 21, 2015

With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.

January 20, 2015

Diplomat Pharmacy on Tuesday announced the addition of Susan Faust to their senior leadership team as VP specialty infusion and market development.

January 20, 2015

Walgreens on Tuesday announced that it has signed a definitive agreement with Madison Dearborn Partners, a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services. 

January 16, 2015

AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease. 

 

January 16, 2015

Walgreens on Thursday announced that effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for Blincyto (blinatumomab).

January 14, 2015

Price Chopper launched a new specialty pharmacy program, which expands pharmacy services in an effort to provide more convenient and personalized solutions for patients.